Infusion of 5-Azacytidine (5-AZA) Into the Fourth Ventricle in Children With Recurrent Posterior Fossa Ependymoma
Status:
Completed
Trial end date:
2018-11-28
Target enrollment:
Participant gender:
Summary
The goal of this clinical research study is to establish the safety of direct administration
of 5-Azacytidine into the fourth ventricle of the brain or resection cavity in patients with
recurrent posterior fossa ependymoma.
Phase:
Early Phase 1
Details
Lead Sponsor:
The University of Texas Health Science Center, Houston